Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone involvement in endocrinopathies]

C Ribot1, F Trémollières, J M Pouillès

  • 1Service d'Endocrinologie, UF Maladies osseuses et métaboliques, CHU Purpan, Toulouse.

Presse Medicale (Paris, France : 1983)
|June 4, 1994
PubMed
Summary

Bone densitometry aids in identifying endocrine disorders affecting bone health. Early detection and management of endocrinopathies are crucial for preventing bone loss and fractures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF).

European journal of obstetrics, gynecology, and reproductive biology·2023
Same author

[Women with a very high risk of breast cancer: Contraceptives, hormonal replacement therapy use and personalized screening].

Gynecologie, obstetrique, fertilite & senologie·2023
Same author

Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.

Maturitas·2022
Same author

Quality of life of patients with bilateral oophorectomy before the age of 45 for the treatment of endometriosis.

Maturitas·2022
Same author

[Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynecologists and Obstetricians (CNGOF)].

Gynecologie, obstetrique, fertilite & senologie·2022
Same author

[Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines (Short version)].

Gynecologie, obstetrique, fertilite & senologie·2021

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Medical Imaging

Context:

  • Endocrinopathies significantly impact bone health, leading to demineralization and increased fracture risk.
  • Advancements in bone densitometry, such as biphotonic absorptiometry, allow for detailed assessment of bone structure.
  • Hormonal imbalances, including hypogonadism, hyperthyroidism, and hypercortisolism, are key contributors to bone loss.

Purpose:

  • To highlight the role of bone densitometry in diagnosing and managing bone abnormalities caused by endocrine disorders.
  • To review the specific effects of various endocrinopathies on cortical and trabecular bone.
  • To emphasize the importance of quantitative and topographical bone evaluation in understanding bone pathophysiology.

Summary:

  • Bone densitometry effectively identifies the impact of endocrinopathies on bone, evaluating both cortical and trabecular structures.
  • Conditions like hypogonadism (in athletes, anorexia nervosa), hyperthyroidism, and hypercortisolism cause significant bone loss and fractures.
  • Other relevant conditions include hyperprolactinism, hypothyroidism, hyperparathyroidism, and acromegaly, all impacting bone mineralization.

Impact:

  • Accurate assessment of bone density is essential for the clinical management of patients with endocrine diseases affecting bone.
  • Understanding the pathophysiology of bone loss in endocrinopathies can guide therapeutic strategies and improve patient outcomes.
  • Early detection through bone densitometry may prevent long-term consequences such as stress and vertebral fractures.

Related Experiment Videos